This website uses cookies to enhance the user experience.
TELEMARK ENERGY AS

TELEMARK ENERGY AS896 917 552

Research
Limited company
Merdevegen 1 3676 NOTODDEN, Norge

TELEMARK ENERGY AS

Telemark Technologies

Keywords

researchdevelopment workbiotechnologygenomicspharmageneticsgene samplesdna sequencingdna synthesisdna deepeninggenetic engineeringproteinsmoleculespeptide sequencinglipidglycotechniqueproteomicshormonesgrowth factorscell receptorspheromonescell culturetissue culturecrossingcell fusionvaccineimmunostimulatorsembryo manipulationprocess biotechnologybioreactorsfermentationbioprocessingbiorecoverybiodesulfurizationbiological pulp productionbiofiltrationbiological regenerationsubcellular organismsgene therapyvirusesvectors

Links

Organization

Chairman of the board
Years since formation
13 years
since May 12, 2011
Type
Limited company
VAT registered
Yes
Number of employees
0

Ownership

Number of shares and share classes
100
1 share class
Total number of shareholders
1
person
Belongs to group of

Financials

Annual total result 2023
-55,532
NOK
Total equity 2023
18,236,521
NOK
Last update: Sep 11, 2024

Management

Management / administration

NameRoleShares
Managing Director/CEO
100 %
directly

Board

NameRoleShares
Chairman
100 %
directly

Others

NameRoleShares
J
JOHRE REVISJON
Auditor-
H
HAUGERUD REGNSKAPSKONTOR AS
Accountant-

Top 10 individual shareholders

NameRoleShares
Managing Director/CEO, Chairman
100 %
directly
Last update: Apr 13, 2023

Ownership

Company shareholders

NameShare classNumber of sharesShare
Ordinary shares
100
100 %

Shares owned by the TELEMARK ENERGY AS

NameShare classNumber of sharesShare
Ordinary shares
519
51.9 %
T
TIL TELEMARK AS
Ordinary shares
5
3.85 %
Last update: May 24, 2024

Group structure

  • Total operating income 2023: NOK 0
    Operating profit 2023: NOK -73,165
    Employees: 0

Financials

in NOK

Summary

Year202320222021
Total operating income
0
14,300
31,822
Annual Total Result
-55,532
-129,541
-238,469
Total assets
24,481,424
23,448,153
24,788,784
Total liabilities
6,244,903
5,156,100
6,367,190
Total equity
18,236,521
18,292,053
18,421,594

P&L

Year202320222021
Total operating income
0
14,300
31,822
Total operating costs
73,165
22,290
95,025
Operating result
-73,165
-7,990
-63,203
Financial income/costs
17,633
-121,550
-183,432
Profit before tax
-55,532
-129,541
-246,635
Total tax & extraordinary income/cost
0
0
-8,166
Annual Total Result
-55,532
-129,541
-238,469

Balance overview

Year202320222021
Total fixed assets
22,778,630
19,278,630
19,272,427
Total current assets
1,702,794
4,169,523
5,516,357
Total assets
24,481,424
23,448,153
24,788,784
Short term debt
367,659
350,140
3,078,166
Long term debt
5,877,245
4,805,960
3,289,024
Total liabilities
6,244,903
5,156,100
6,367,190
Contributed capital
100,000
100,000
100,000
Retained earnings
18,136,521
18,192,053
18,321,594
Total equity
18,236,521
18,292,053
18,421,594
Total equity and liabilities
24,481,424
23,448,153
24,788,784

Classification

Category
Type of organization
Limited company
Classification of institutional sector
INNL
Domestic sectors
A_IKKE-FIN
Non-financial corporations
2100
Private non-financial incorporated enterprises
Standard industrial classification
M
Main industrial area
Professional, scientific and technical activities
72
Activity
Scientific research and development
72.1
Main industrial group
Research and experimental development on natural sciences and engineering
72.11
Industrial group
Research and experimental development on biotechnology
72.110
Industrial group
Research and experimental development on biotechnology